Join our daily newsletter At The Bell to receive exclusive market insights
- IMEXHS (IME), through its subsidiary RIMAB, wins a radiology services contract with Colombia’s fifth-largest insurance provider, Famisanar
- Famisanar serves more than 2.4 million patients across 16 departments in Colombia
- Under today’s deal, RIMAB will carry out Famisanar’s MRI studies for patients across the nation’s Cundinamarca region
- The contract will last for four months, with automatic renewals thereafter, and will offer IME annual recurring revenue (ARR) of around $1.1 million
- IMEXHS shares are up 4.88 per cent, trading at 43 cents at 12:35 pm AEDT
IMEXHS (IME), through its subsidiary RIMAB, has won a new radiology services contract with Colombia’s fifth-largest insurance provider, Famisanar.
Famisanar serves more than 2.4 million patients across 16 departments in Colombia.
Under today’s deal, IMEXHS’ RIMAB will carry out Famisanar’s MRI studies for patients across Colombia’s Cundinamarca region. The agreement includes a fixed monthly package of 1500 MRI studies.
IMEXHS Co-Founder and CEO Germán Arango said the company was delighted to partner with one of Colombia’s leading insurance providers.
“We are delighted to partner with one of Colombia’s most important insurance providers,” Dr Arango said.
“Our ability to provide high-tech medical imaging technology as well as patient-centric radiology services, thanks to our 150-plus highly trained radiologists, makes our offering unique across Latin America and most parts of the globe.”
The contract lasts for four months but includes automatic four-month renewals thereafter.
IMEXHS expects the deal to contribute an estimated $1.1 million in annual recurring revenue (ARR) to its bottom line.
IMEXHS shares were up 4.88 per cent and trading at 43 cents at 12:35 pm AEDT.
